Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Researchers have identified sequential diagnostic patterns that may enhance early detection and improve strategies for disease prevention. Researchers at UCLA Health have uncovered four distinct ...

Functional movement disorders (FMD) are proposed to reflect a specific problem with voluntary control of movement, despite normal intent to move and an intact neural capacity for movement. In many ...

This paper focuses on developing a Machine Learning (ML) framework for classifying neurological disorders using longitudinal Resting State Functional Magnetic Resonance Imaging (rs-fMRI) samples.

Telehealth neurological services are already available at Helen Keller Hospital. That means the on-call neurologist at Huntsville Hospital can help consult with patients from 75 miles away.

Explore new insights into brain function and neurological disorders through a unified theory of criticality, emphasizing its role in learning and cognitive health.

At the 11th Congress of the European Academy of Neurology, which was held in Helsinki June 21 to June 24, researchers presented new data on using CAR T cells in autoimmune neurological conditions.

Functional neurological disorder (FND) is a prevalent, disabling and costly condition at the neurology–psychiatry intersection. After being marginalised in the late 20th century, there has been ...

Neuropsychiatric disorders reflect disruptions in brain network dynamics along an “order–complexity–chaos” continuum. Psychedelics may therapeutically increase neural entropy, disrupt maladaptive ...

At the 11th Congress European Academy of Neurology, which was held in Helsinki June 21 to June 24, researchers presented new data on using CAR T cells in autoimmune neurological conditions.